About Pieter Wyckmans

Pieter Wyckmans provides expert advice to companies and organisations active in the (bio)pharmaceutical, biotech and smart devices sectors. Pieter co-heads the life sciences department of Quinz. His transactional expertise covers the entire life cycle of a drug product (R&D, clinical trials, supply chain and technical operations, commercial distribution), including M&A, product divestments and licensing deals. Pieter has developed a particular life sciences regulatory expertise under EU and national laws. More specifically, he provides his clients with expert advice on a broad array of legal and strategic issues regarding clinical trials and market access, including early-access programmes, marketing authorisation procedures, and pricing and reimbursement. Pieter worked in-house for the legal department of UCB.